Abstract
In this paper I analyse who should be able to control the use of human embryonic stem cell lines. I distinguish between different kinds of control and analyse a set of arguments that purport to show that the donors of gametes and embryos should not be able to control the use of stem cell lines derived from their embryos. I show these arguments to be either deficient or of so general a scope that they apply not only to donors but also to those who derived the stem cell lines. Since we normally think that stem cell derivers have the right to control the use of the cell lines they derived, we have no justification for denying donors similar rights of control. In the final section I briefly discuss why informed consent is not an appropriate vehicle for transferring or alienating control rights.
Similar content being viewed by others
Notes
World Medical Association Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects: Adopted by the 18th WMA General Assembly Helsinki, Finland, June 1964 and amended by the 29th WMA General Assembly, Tokyo, Japan, October 1975, 35th WMA General Assembly, Venice, Italy, October 1983, 41st WMA General Assembly, Hong Kong, September 1989, 48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996 and the 52nd WMA General Assembly, Edinburgh, Scotland, October 2000. Note of Clarification on Paragraph 29 added by the WMA General Assembly, Washington 2002, Note of Clarification on Paragraph 30 added by the WMA General Assembly, Tokyo 2004.
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use.
It is probably misleading to talk about the genetic parents of a cloned embryo, or an embryo produced from cells that are not derived directly from an adult human being. It is misleading because it trades on an equivocation on the term ‘parent’. In one sense (the genetic) an embryo can be a parent, but in another and equally important sense (the social) an embryo can never be a parent. Since genetic parents are still, for the most part, also social agents (e.g., egg and sperm donors), the use of the term ‘genetic parent’ does not sufficiently guard against the equivocation. A better term would probably be ‘immediate genetic progenitor.’
References
Callahan, D. (1972). Abortion: Law, choice and morality. New York: Macmillan.
Canadian Institutes of Health Research. (2005). Updated guidelines for human pluripotent stem cell research, June 7, 2005.
Denker, H.-W. (2004). Early human development: New data raise important embryological and ethical questions relevant for stem cell research. Naturwissenschaften, 91, 1–21.
Dworkin, R. (1993). Life's dominion. London: Harper Collins.
Engelhardt, H. T. (1986). The foundations of bioethics. New York: Oxford University Press.
Fletcher, J. (1972). Indicators of humanhood: A tentative profile of man. The Hastings Center Report, 2(5), 1–4.
Geijsen, N., Horoschak, M., Kim, K., et al. (2004). Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature, 427(6970), 148–154.
Glover, J. (1977). Causing deaths and saving lives. Harmondsworth: Penguin.
Hahn, W. C. (2002). Immortalization and transformation of human cells. Molecules and Cells, 13(3), 351–361.
Harris, J. (1985). The value of life. London: Routledge & Kegan Paul.
Harris, J. (2004). On cloning. London: Routledge.
Heller, M. A., & Eisenberg, R. S. (1998). Can patents deter innovation? The anticommons in biomedical research. Science, 280(5364), 698–701.
Holm, S. (1986). Hvem afgør liv eller død – De etiske problemer ved prænatal diagnostik. København: Scandinavia.
Holm, S. (1989). The peacable pluralistic society and the question of persons. Journal of Medicine and Philosophy, 13, 379–386.
Holm, S. (1993). The spare embryo – A red herring in the embryo experimentation debate. Health Care Analysis, 1(1), 63–66.
Holm, S. (1996). The moral status of the pre-personal human being – The argument from potential reconsidered. In D. Evans (Ed.), Conceiving the embryo (pp. 193–220). Dordrecht: Kluwer.
Holm, S. (2003a). The ethical case against stem cell research. Cambridge Quarterly of Health Care Ethics, 12, 372–383.
Holm, S. (2003b). Does the end sanctify the means? In L. Honnefelder & D. Lanzerath (Eds.), Cloning in biomedical research and reproduction (pp. 427–436). Bonn: Bonn University Press. [German version in same volume p. 61–72].
Holm, S. (2004). The creation lottery and method in bioethics: A comment on Savulescu and Harris. Cambridge Quarterly of Health Care Ethics, 13, 283–287.
Hong, M.-K., & Bero, L. A. (2002). How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ, 325, 1413–1416.
Jansen, R. (1985). Sperm and ova as property. Journal of Medical Ethics, 11, 123–126.
Lo, B., Chou, V., Cedars, M. I., et al. (2004). Informed consent in human oocyte, embryo, and embryonic stem cell research. Fertility and Sterility, 82(3), 559–563.
Mackie, J. L. (1980). The cement of the universe: A study in causation. Oxford: Oxford University Press.
Marquis, D. (1989). Why abortion is immoral. The Journal of Philosophy, 86, 183–202.
Masters, J. R. (2002). HeLa cells 50 years on: The good, the bad and the ugly. Nature Reviews, 2, 315–319.
McCormick, R. A. (1981). How brave a new world? London: SCM Press.
Medical Research Council. Code of practice for the use of human stem cell lines (Version 1 – April 2004) – Annex 2a – Donating embryos for stem cell research donor information and consent form. Available from: www.mrc.ac.uk/pdf-stem_cell_lines_code_draft-a2a.pdf (accessed 19.04.05).
Moore v. The Regents of the University of California, 793, P.2d 479 (Cal 1990).
Nagy, A., Rossant, J., Nagy, R., et al. (1993). Derivation of completely cell culture-derived mice from early passage embryonic stem cells. Proceedings of the National Academy of Science, 90, 8424–8428.
National Bioethics Advisory Commission. Research involving human biological materials: Ethical issues and policy guidance (Volume I Report and Recommendations of the National Bioethics Advisory Commission). Rockville, Maryland: National Bioethics Advisory Commission; 1999.
Office for the Protection from Research Risks. Issues to consider in the research use of stored data or tissues. November 7, 1997.
Oviedo Convention of the Council of Europe (1997). (Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: Convention on Human Rights and Biomedicine – ETS No. 164).
Radin, M. J. (1996). Contested commodities. Cambridge: Harvard University Press.
Ramsey, P. (1970). Fabricated man. New Haven: Yale University Press.
Ramsey, P. (1978). Ethics at the edges of life. New Haven: Yale University Press.
RAND. (2003). Case studies of existing human tissue repositories: “Best practices” for a biospecimen resource for the genomic and proteomic Era. Santa Monica, California: RAND.
Robertson, J. A. (1986). Embryos, families, and procreative liberty: The legal structure of the new reproduction. Southern California Law Review, 59, 939–1041.
Robertson, J. A. (1994). Children of choice. Princeton: Princeton University Press.
Singer, P. (1979). Practical ethics. Cambridge: Cambridge University Press.
Skloot, R. (2000). Henrietta's dance. Johns Hopkins Magazine, April 2000. Available from: http://www.jhu.edu/~jhumag/0400web/01.html (accessed 19.04.05).
Smith, V. (2002). Wonder woman: The life, death, and life after death of Henrietta Lacks, unwitting heroine of modern medical science. Baltimore City Paper, April 17.
Stacey, G. N. (2000). Cell contamination leads to inaccurate data: We must take action now. Nature, 403(6768), 356.
Tanaka, M., Hadjantonakis, A. K., & Nagy, A. (2001). Aggregation chimeras. Combining ES cells, diploid and tetraploid embryos. Methods in Molecular Biology, 158, 135–154.
Testa, G., & Harris, J. (2004). Ethical aspects of ES Cell-derived gametes. Science, 305, 1719.
Testa, G., & Harris, J. (2005). Ethics and synthetic gametes. Bioethics, 19(2), 146–166.
The Ethics Committee of the American Society for Reproductive Medicine. (2004). Donating spare embryos for embryonic stem-cell research. Fertility and Sterility, 82(Suppl. 1), S224–S227.
Tooley, M. (1985). Abortion and infanticide. Oxford: Oxford University Press.
Warren, M. A. (1973). On the moral and legal status of abortion. The Monist, 57, 43–61.
Warren, M. A. (1997). Moral status: Obligations to persons and other living things. Oxford: Clarendon Press.
Acknowledgments
My thinking on these issues has been stimulated by participation in three research projects sponsored by the Commission of the European Union, DG-Research, EUROSTEM, EUROSTEMCELL, EURECA, and by coordinating a project entitled “Going to the roots of the stem cell controversy,” sponsored by The Research Council of Norway. The views expressed in this paper are not necessarily the views of any of the projects mentioned. The paper has been considerably improved due to helpful comments on previous versions of the manuscript from two anonymous reviewers and the issue guest editors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Holm, S. Who Should Control the Use of Human Embryonic Stem Cell Lines: A Defence of the Donors' Ability to Control. Bioethical Inquiry 3, 55–68 (2006). https://doi.org/10.1007/s11673-006-9004-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11673-006-9004-7